Sensitive ASX Announcement

Microba Commences Phase I Clinical Trial for IBD Therapeutic

Published: 28/06/23, 09:04am (AEST)2 pages
Microba Life Sciences Limited
MAP:ASXHealthcare

Recent MAP Announcements

Price Sensitive only